Trademark: 79368859
Word
ONCOBODIES
Status
Pending
Status Code
686
Status Date
Tuesday, February 20, 2024
Serial Number
79368859
Mark Type
4000
Filing Date
Thursday, February 2, 2023
Published for Opposition
Tuesday, February 20, 2024

Trademark Owner History
LinXis B.V. - Owner At Publication

Classifications
5 Drug delivery agents in the form of powders, tablets and capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; biochemical medicines for the treatment of cancer; chemical preparations for pharmaceutical purposes, namely, for the treatment of cancer; diagnostic agents for pharmaceutical purposes; pharmaceutical substances and preparations for the treatment of cancer
1 Chemical additives for use in the manufacture of pharmaceuticals; chemical preparations for use in the manufacture of pharmaceuticals; active chemical ingredients for use in the manufacture of pharmaceuticals; carrier excipients for use in the manufacture of pharmaceutical preparations
44 In vitro analysis for medical and pharmaceutical use, namely, analysis for medical diagnostic or treatment purposes; in vitro testing for medical and pharmaceutical use, namely, testing for medical diagnostic or treatment purposes; consultancy and information services provided via the Internet relating to pharmaceutical products, namely pharmaceutical consultation
42 Pharmaceutical research services; scientific research in the nature of conducting clinical trials for pharmaceuticals for others; pharmaceutical research and development; pharmaceutical product evaluation; consultancy relating to pharmaceutical research and development; laboratory research services relating to pharmaceuticals; providing information about the results of clinical trials for pharmaceuticals; providing information about medical and scientific research in the field of pharmaceuticals; research services in the field of proteins, antibodies, microorganisms and cells; research and development services in the field of antibody technology; design and development of medical technology
The wording "ONCOBODIES" has no meaning in a foreign language.

Trademark Events
Mar 4, 2024
Official Gazette Publication Confirmation E-Mailed
Feb 27, 2024
Notification Processed By Ib
Feb 20, 2024
Published For Opposition
Feb 7, 2024
Notification Of Possible Opposition Sent To Ib
Feb 7, 2024
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Feb 1, 2024
Official Gazette Publication Confirmation E-Mailed
Jan 31, 2024
Notification Of Notice Of Publication E-Mailed
Jan 18, 2024
Approved For Pub - Principal Register
Dec 27, 2023
Teas/Email Correspondence Entered
Dec 27, 2023
Correspondence Received In Law Office
Dec 27, 2023
Teas Response To Office Action Received
Nov 28, 2023
Refusal Processed By Ib
Nov 7, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Nov 7, 2023
Refusal Processed By Mpu
Nov 7, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Nov 6, 2023
Non-Final Action Written
Nov 1, 2023
Assigned To Examiner
May 9, 2023
Application Filing Receipt Mailed
May 5, 2023
New Application Office Supplied Data Entered
May 4, 2023
Sn Assigned For Sect 66a Appl From Ib

Trademark Alertz updated from USPTO on 2030-01-24